Alpha-fetoprotein (AFP), as one of the most basilic tumor biomarkers, with a molecular weight about 70,000 Da, is normally used for routine cancer screening in clinical laboratories because it is universally associated with many cancer incidences, including gastric, breast, colorectal, and liver cancers [26,27,28,29]. This evidence concerns the gene AFP and neoplasm.